Transcriptional regulation of the human establishment of cohesion 1 homolog 2 gene

Biochemical and Biophysical Research Communications
Masahiro NishiharaItaru Yanagihara

Abstract

Transcriptional regulation of human establishment of cohesion 1 homolog 2 (ESCO2), the causative gene of Roberts syndrome, was investigated. Deletion and mutation analyses of the ESCO2 promoter indicated that the selenocysteine tRNA-activating factor (Staf) binding site (SBS) is an essential element for transcriptional activation of ESCO2. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay revealed that the zinc finger protein 143 (ZNF143), a human homolog of Xenopus Staf, bound to the ESCO2 promoter. The ACTACAN submotif, adjacent to SBS, also contributed to transcriptional activation of ESCO2. EMSA indicated that the ACTACAN submotif was not involved in binding of ZNF143 to SBS. S phase-specific expression of the ESCO2 gene was confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR), but EMSA revealed binding of ZNF143 to SBS in G1/S and G2/M phases. These results demonstrated that SBS functioned as the basal transcriptional activator of the S phase-specific gene ESCO2, but other mechanisms are required for cell cycle-dependent expression.

References

Aug 15, 1998·The Journal of Biological Chemistry·E MyslinskiP Carbon
Apr 25, 2000·Nucleic Acids Research·M SchaubP Carbon
Jun 12, 2002·Molecular Biology of the Cell·Michael L WhitfieldDavid Botstein
May 5, 2007·Nucleic Acids Research·Evelyne MyslinskiPhilippe Carbon
Jul 26, 2008·Science·Tom Rolef Ben-ShaharFrank Uhlmann
Jul 26, 2008·Science·Elçin UnalDouglas E Koshland

❮ Previous
Next ❯

Citations

Sep 10, 2010·Biology of Reproduction·Cathryn A HogarthMichael Griswold
Jun 16, 2012·Biology of Reproduction·Elizabeth B EvansMichael D Griswold
Jun 15, 2012·Development, Growth & Differentiation·Akihiro MoritaItaru Yanagihara
Feb 4, 2012·Disease Models & Mechanisms·Masayuki NakanoHisao Kurazono
Sep 30, 2015·Molecular and Cellular Biology·Aurimas VinckeviciusDebabrata Chakravarti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.